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ABSTRACT
Single ventricle hearts are congenital cardiovascular defects in which the heart has
only one functional pumping chamber. The treatment for these conditions typically requires a
three-staged operative process where Stage 1 is typically achieved by a shunt between the
systemic and pulmonary arteries, and Stage 2 by connecting the superior venous return to the
pulmonary circulation. Surgically, the Stage 2 circulation can be achieved through a
procedure called the Hemi-Fontan, which reconstructs the right atrium and pulmonary artery
to allow for an enlarged confluence with the superior vena cava.
Based on pre-operative data obtained from two patients prior to Stage 2 surgery, we
developed two patient-specific multi-scale computational models, each including the 3D
geometrical model of the surgical junction constructed from magnetic resonance imaging, and
a closed-loop systemic lumped-parameter network derived from clinical measurements.
“Virtual" Hemi-Fontan surgery was performed on the 3D model with guidance from clinical
surgeons, and a corresponding multi-scale simulation predicts the patient’s post-operative
hemodynamic and physiologic conditions. For each patient, a post-operative active scenario
with an increase in the heart rate (HR) and a decrease in the pulmonary and systemic
vascular resistance (PVR and SVR) was also performed. Results between the baseline and
this ‘active’ state were compared to evaluate the hemodynamic and physiologic implications
of changing conditions.
Simulation results revealed a characteristic swirling vortex in the Hemi-Fontan in both
patients, with flow hugging the wall along the SVC to Hemi-Fontan confluence. One patient
model had higher levels of swirling, recirculation, and flow stagnation. However, in both
models, the power loss within the surgical junction was less than 13% of the total power loss
in the pulmonary circulation, and less than 2% of the total ventricular power. This implies
little impact of the surgical junction geometry on the SVC pressure, cardiac output, and other
systemic parameters. In contrast, varying HR, PVR, and SVR led to significant changes in
theses clinically relevant global parameters.
Adopting a work-flow of customized virtual planning of the Hemi-Fontan procedure with
patient-specific data, this study demonstrates the ability of multi-scale modeling to reproduce
patient specific flow conditions under differing physiological states. Results demonstrate that
the same operation performed in two different patients can lead to different hemodynamic
characteristics, and that modeling can be used to uncover physiologic changes associated
with different clinical conditions.
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INTRODUCTION
Single ventricle physiology, in which the infant has only one functional pumping
chamber, is one of the most severe forms of congenital heart disease. Without intervention,
the condition is not compatible with life, requiring immediate surgical treatment after birth,
followed by two additional surgeries within the first few years of life. The surgeries are
staged such that at each stage the circulation provides adequate systemic oxygen delivery
without severe, long-term volume overloading of the ventricle. The final goal is to bypass the
heart by connecting the entire systemic venous return directly to the pulmonary arterial
system, resulting in an in-series circulation driven by a single ventricle(1).
The Stage 1 surgery is performed within the first few days of life, with the patency of
the ductus arteriosus ensured by infusion of prostaglandin E2 until the operation. In most
cases a systemic-to-pulmonary shunt (Fig. 1a) provides balanced flow to the pulmonary
circulation while maintaining an unrestricted aortic outflow and systemic venous return. The
stage 2 surgery is performed at about 6 months of age, after the pulmonary vascular
resistance has decreased due to lung growth (2). The surgery removes the systemic-topulmonary shunt, or disconnects the pulmonary artery from the systemic arterial circulation
(depending on stage 1 anatomy), and attaches the superior vena cava (SVC) to the
pulmonary artery to provide pulmonary flow. After a few years of age as the proportion of
systemic venous return from the lower body increases, the stage 3 surgery, the Fontan
procedure, is performed, during which the inferior vena cava (IVC) is also connected to the
pulmonary artery, completing the conversion to single ventricle circulation.
The transition from Stage 1 to Stage 2 circulation is particularly important as the single
ventricle is relieved of the workload of providing pulmonary blood flow, which is then solely
derived from the superior vena cava (SVC). In addition to requiring low pulmonary vascular
resistance to allow for effective Stage 2 circulation, the surgical reconstruction required to
provide a pulmonary blood flow devoid of a ventricular power source must be one that
extracts little power or energy. The Hemi-Fontan (HF) operation has been adopted by many
surgeons as the preferred procedure to achieve these goals. Figure 1b demonstrates one
version of this operation, in which the SVC remains connected to the right atrium, and a
homograft patch is placed to redirect flow to the right and left pulmonary arteries through a
small pouch or confluence.
Due to the lack of animal models for single ventricle physiology, and the fact that direct
clinical measurements are often difficult, the understanding of the impact of the surgical
geometries and patient-specific anatomy on important clinical parameters, such as ventricular
load, thrombotic risk, or systemic pressures and flows, remains challenging. Computational
methods have been used to study patient-specific single ventricle physiology, and predict
hemodynamic changes due to virtual surgery (3-8). Using a coupled multi-scale and closedloop modeling approach, realistic local and global hemodynamic interactions can be mimicked
and detailed holistic, physiologic information can be extracted for in-depth analysis to better
compare different surgical options.
In this study, we performed virtual HF operation on two patients who had undergone
clinical investigation prior to conversion from Stage 1 to Stage 2 circulation. For each patient
we investigated the local dynamics of the Hemi-Fontan circulation, and analyzed the global
systemic physiology of each under a normal resting state, as well as an “active” state, which
mimics voluntary arm and leg movements of the infant with increased heart rate and blood
flow.
METHODS
This study utilizes patient-specific computational models to describe various scenarios
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after the HF surgery for two single-ventricle patients. Each computational model contains a
3D domain of the surgical junction, and a 0D domain that describes the rest of the circulatory
system. A total of 4 simulations were performed for this study, encompassing a resting and
an active condition for the two patients.
Clinical Data Acquisition
The patients A and B were 5 and 6 months old at the time of surgery, respectively, with
body surface areas (BSA) of 0.3 m2 and 0.34 m2. Patients A and B were recruited the
Medical University of South Carolina, Charleston SC, and the University of Michigan, Ann
Arbor, MI, respectively. The study was approved by the IRB at each institution. For patient A
the MRI was performed 1.5 months prior to surgery, immediately following cardiac
catheterization under the same general anesthesia. For patient B the MRI was performed
immediately prior to surgery under the same anesthetic, and cardiac catheterization was
performed 3 days prior to the MRI and surgery. MRI data was obtained using a standardized
protocol, including a contrast-enhanced 3-dimensional MR angiogram, following the
administration of 0.2 mmol/kg of gadoteridol (Prohance, Bracco Diagnostics, Princeton, New
Jersey). In-plane spatial resolution for the angiogram was 1.0 x 1.0 mm, with slice thickness
of 2.0 mm, interpolated to 1.0 mm.
Construction of 3D Surgical Junction Geometries
Based on magnetic resonance imaging data of each patient prior to the Stage 2
surgery, we reconstructed the patient anatomy using commercial software (Mimics,
Materialise NV, Leuven, Belgium). We selected regions of interest in the imaging data, and
used a segmentation and region-growing technique (9, 10) to obtain a 3D volume of the
relevant vasculature. The resulting 3D model is a representation of the patient's preoperative anatomy (Fig. 2b).
Once the pre-operative anatomical models are created, these can be manipulated
using the same software (Mimics) in order to generate virtual post-operative scenarios. We
performed the HF virtual surgery by modifying the pre-operative 3D model based on the
geometric constraints relating to the organs and vessels surrounding the region. The postoperative models were created by following the clinical guidelines of the respective
procedures, and by the same operator who generated the pre-operative models. The
imaging-based virtual modification of the patient anatomy allows for patient-specific
predictions of post-operative geometries. For example, the post-operative deformation of the
SVC is affected by the pulmonary artery geometry at the point of anastomosis. Using this
method, we can produce a predictive HF post-operative 3D geometrical model for each
patient (Fig. 2a). Patient A had a left pulmonary stenosis that was palliated in the virtual
surgery, mimicking a realistic clinical scenario. Both the HF virtual surgeries were performed
by an engineer and a pediatric cardiac surgeon working together, and approved by a second
surgeon from our research group.
0D Lumped-parameter Network
To model the circulatory system outside of the 3D anatomical region, we use a 0D
lumped-parameter network (LPN). The LPN consists of five main circuit blocks to model the
heart, the upper and lower body vasculatures, and the right and left pulmonary vasculatures
(Fig. 3). Two time-varying elastances represent the atrium and ventricle, where two
activation functions properly shifted in time model contraction of the two chambers. The
atrio-ventricular and aortic valves are modeled by non-linear diodes allowing for unidirectional
flow with resistances proportional to the flow rate. In the lower body we modeled three organ
4

systems (kidneys, liver and intestine) and a venous valve in the leg venous block.
Corresponding to the outlets of the 3D model, a number of RCR blocks arranged in parallel
describe the pulmonary circulation. Coronary circulation, gravity and respiratory effects are
neglected(11).
We prescribed the pulmonary LPN parameter values using a morphometric tree based
impedance approach (12, 13). The parameters result from a 3D-0D preliminary study
utilizing patient-specific preoperative clinical data of the transpulmonary pressure gradient,
total pulmonary flow, left-right pulmonary flow split, and the size of each pulmonary branch
outlet (13). The pulmonary vascular resistance can be calculated as:
PVR=

P PA− P SA
Q PA

(1)

where PPA, PSA and QPA are the mean pulmonary arterial pressure and atrial pressures,
and total pulmonary flow, respectively.
For the systemic LPN parameters, we began with a set of values representing a
generic single ventricle subject with BSA=1.8 m2 (14-16) and used allometric equations to
scale the parameters according to the patient’s BSA (17). This resulted in a BSA-adjusted
generic LPN model, with resistance and capacitance values indicated as Ri-BSA and Ci-BSA for
the ith-block. We then tuned the LPN to the patient's resting condition using the resistances
of the upper and lower body (UBSVR and LBSVR, respectively) calculated by:
UBSVR=

P SysA− P SA

LBSVR=

QUBA

P SysA − P SA
Q LBA

(2)

where PSysA, QUBA, and QLBA are the pre-operative (stage 1) clinical measurements of the
mean systemic arterial pressure, upper body flow, and lower body flow, respectively.
While maintaining the proportion of impedances among the different blocks, we
modified the resistances of each block (resulting in Ri) such that the clinically measured
UBSVR and LBSVR from equations 2 are achieved. We then calculated the patient-specific
compliance Ci of the ith-block using (17, 18):
C i =C i − BSA

(

Ri
Ri − BSA

− 4/ 3

)

(3)

Lastly, we manually fine-tuned the parameter values to best match both the mean
values and waveform tracings from clinical flow measurements made during resting
conditions. The heart rate for both patient models is set to 120bpm, which is within the
range of the measured heart rate in both patients.
For each patient, we also prescribed a set of LPN parameter values to reflect an
“active” condition, which approximates the patient’s physiology during voluntary movements
of the limbs and increased blood flow. We chose an “active” state of an infant to parallel an
“exercise” state of an older patient capable of exercising. For the active condition, we
assume an increase in heart rate from 120bpm to 160bpm(19), and decreases in PVR and
total SVR of 20% and 34%, respectively. Starting from the patient-specific tuned resting
condition LPN model, parameters were systematically tuned, as above, to achieve a set of
desired values to model the active state. The compliances were modified according to the
equation:
− 3 /4
Ri − active
C i − active = Ci
Ri
(4)

(

)

where Ci, Ri are the compliances and resistances of the ith-block in the model under resting
condition, and Ri-active are the resistances of the ith-block under active condition(20). All other
5

model parameters and fluid properties were kept fixed. In patient A, the PVR and SVR were
0.62 and 4.30 mmHgꞏs/ml for the resting condition, and 0.49 and 2.87 mmHgꞏs/ml for the
active condition, respectively; for patient B the PVR and SVR were 1.07 and 2.68 mmHgꞏs/ml
for resting and 0.86 and 1.75 mmHgꞏs/ml for active condition, respectively.
Coupled Multi-scale Simulation & Analysis
Each of the 3D anatomic models was discretized into an isotropic finite-element mesh
with a maximum edge size of 0.03 cm and a total of 9.8x105 ~ 1.3x106 linear tetrahedral
elements using commercial mesh generation software (MESHSIM, Simmetrix, Inc., NY).
These mesh sizes were similar or higher compared to prior studies of corresponding
anatomy(21-23). We coupled the 3D anatomical model to the 0D LPN model to produce a
final computational model that described the entire circulation, and numerically solved the
coupled system using custom software (Simvascular, www.simtk.org). Neumann boundary
conditions were applied at all inlets and outlets of the 3D model using an implicit coupling
algorithm described in our previous work(24) in which the 3D domain receives pressure
information from the 0D model, and returns flow information to the 0D model, thus completing
the two-way coupling between the multi-scale domains. Flow and pressure in the 0D model
were computed from a set of algebraic and ordinary differential equations derived from the
LPN circuit, using a 4th order Runge-Kutta method. Velocity and pressure in the 3D domain
were computed using a custom incompressible finite element Navier-Stokes solver, assuming
rigid walls and a Newtonian fluid with density of 1.06 g/cm3 and dynamic viscosity of 0.04
dynes-s/cm2. The solver uses a stabilized scheme (25) and outflow stabilization to prevent
backflow divergence(26). The method allows for modular coupling of the 3D and 0D
domains without the need for intrusive changes to the finite element solver, and eliminates the
small time step stability restriction imposed by explicit coupling methods in previous work. The
choice of rigid walls is justified by our recent unpublished work showing little difference in
energy loss and pressure levels, though non-negligible differences in wall shear stress
(WSS), in rigid vs. deformable simulations. For each simulation we used a time step size of
1 millisecond for the 3D domain, and 1 microsecond for the 0D domain. 12 cardiac cycles
were simulated and the last cycle was used in the analysis.
Based on the computed 3D velocity field from the simulation, we computed WSS and
particle residence time (PRT), which is the time needed for entering particles to exit the 3D
HF junction domain. We also obtained the local hemodynamic power dissipation in the
surgical region by integrating the difference between the inlet and outlet energy fluxes of the
3D model, accounting for both the potential and kinetic energy terms(27). Pressure and flow
information at various points in the 0D LPN model were also extracted. The instantaneous
pulmonary power loss is calculated as the sum of the power losses in all of the pulmonary
blocks:
PW pul =  ( Poutlet  PSA )  Qoutlet
(5)
outlets

where Poutlet, PSA, and Qoutlet are the pressure at each outlet of the 3D model, the atrial
pressure, and the volumetric flow through each outlet of the 3D model, respectively. The
pulmonary power loss can then be averaged over the cardiac cycle to obtain a mean value.
The ventricular output power is the difference between the work done to the blood by the
ventricle, and vice versa, during the ejection and filling phases:
PWven = (  PSV  VSV dt -  PSV  VSV dt) / T
(6)
systole

diastole

where PSV, VSV, and T are the ventricular pressure, ventricular volume, and the cardiac cycle
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period, respectively.
RESULTS
Figures 4a) and 5a) show the volume rendered flow velocity field magnitude (color
map) and directions (arrows) in the 3D surgical junction for patients A and B. For both
patient models, the incoming flow from the SVC tends to glide along the curve of the
confluence floor. In patient A the SVC flow transitions fairly smoothly into the pulmonary
arteries. However, in patient B significant swirling is observed, leading to high velocities
around the circumference, resulting in a low flow and stagnation region near the center of the
confluence section.
Figures 4b) and 5b) show the WSS distribution in the surgical junction for the two
patients. In general, WSS is fairly uniformly distributed, with a band of high WSS
corresponding to the orientation of the swirling flow in the junction. The spatial pattern of
WSS is similar between the resting and active conditions simulated.
Table 1 shows the average values of different parameters extracted from each
simulation. The junction power loss associated with the HF in patient B is approximately 3
times of that in patient A, however, the amount of power loss associated with the HF region
remained less than 13% of the total power loss in the pulmonary circulation, and less than 2%
of the total ventricular output power in all cases.
For both patients, the systemic parameters are significantly affected by changes in the
physiological condition, but with different magnitudes. The active state led to increased
cardiac output and pulmonary blood flow, and a corresponding increase in SVC pressures in
both models. Coupled with an already higher baseline SVC pressure of 15.5 mmHg, Patient
B had a much higher SVC pressure in the active condition than Patient A (18.8 vs. 11.7
mmHg, respectively).
Figure 6 shows the ventricular pressure-volume loop and the SVC pressure for all
cases. The area inside the pressure-volume loop for the active condition is smaller than that
for the resting condition in both patients, indicating that less work is performed during each
individual cardiac cycle. However, due to the higher heart rate, the ventricular output power
(work divided by time) in the active condition is higher than that in resting.
The mean WSS is higher in the active state compared to the resting state (82% and
75% higher, for patients A and B, respectively). The mean PRT, on the other hand, is higher
in the resting state compared to the active state (50% and 41% higher, for patients A and B,
respectively).
DISCUSSION
This study demonstrates the potential of multi-scale techniques to study the
hemodynamics and physiology of Stage 2 circulation with the HF procedure in patients with
single ventricle circulation. A coupled closed-loop multi-scale modeling approach was used
to mimic realistic post-operative scenarios in two patients based on pre-operative clinical
data. This method allowed assessment of both local dynamic and global physiologic
parameters in a patient-specific manner, and demonstrated that even with the same type of
operation, differences in hemodynamic outcomes can occur. Moreover, these differences can
be accentuated by virtually ‘stressing’ the circulation by changing parameters to mimic
physiologic conditions in an active state. By varying modeling parameters, such as heart rate
and systemic/pulmonary vascular resistances, this methodology provides important insights
into the effects of changes in physiologic condition on the Stage 2 circulation.
The power loss results are in the same range as reported by previous modeling studies
of the HF anatomy(22, 23). The simulation results show significant differences in the 3D
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velocity patterns in the surgical domains in the two different patients, leading to visible
variations in power loss. Patient B exhibited three times higher power loss due to higher
degrees of flow disturbances and flow rates. However, relative to the global systemic
powers, such as the pulmonary circulation power loss and ventricular power, the power loss in
the surgical domain is small and may not have a large influence on the overall circulation. The
observed differences in global flow and pressures, for example cardiac output and SVC
pressure, between Patient A and B were primarily due to differences in patient-specific
physiologic parameters such as pulmonary vascular resistance. These results therefore imply
that further refinement of the HF operation and improvements in the surgical junction power
loss is likely to have minimal impact on the overall immediate post-operative circulation and
physiology in terms of pressure and flow, at least during resting and regular active conditions.
Nevertheless, refinement of the HF operation may consider the optimization of
minimizing thrombotic risk. Results from computational simulations such as PRT and WSS
can contribute to assessing the relative thrombotic risks between the different cases. The
lower PRT during the active condition may be beneficial for reducing thrombotic risk.
However, the higher WSS during the active state may pose risks of platelet activation. The
peaking levels of WSS observed in the scenarios investigated are within the range where
shear-induced platelet activation is possible (28).
The observation that the active condition increased the surgical junction power loss
can be explained by considering the junction as a non-linear resistance with a value
proportional to the square of the flow rate(29). Auto-regulation mechanisms also act to
increase vessel diameters during an active state, decreasing vascular resistance in response
to increased flow (30). This was included in the models by the chosen changes in PVR and
SVR. For these reasons, with increasing cardiac output, the surgical junction power loss
increases at a faster rate than systemic power losses. The surgical junction power loss
relative to systemic losses thus will become more significant at higher cardiac output. The
power loss difference between the two HF models could become important and have more
tangible effects on systemic parameters with more extreme physiological conditions such as
strenuous activity (27). As noted in the active condition simulation, the increase in SVC
pressure for patient B is more exaggerated than patient A, with pressures reaching 19 mmHg.
This has important clinical ramifications. While most patients would tolerate an SVC
pressure up to 15 to 16 mmHg, at 19 mmHg it is likely that patient B would exhibit clinical
signs of SVC syndrome or superior venous hypertension, with facial swelling, headache, and
orbital edema, based on prior clinical experience.
This study demonstrates that, in the Stage 2 circulation, while differences in local
dynamics and power loss can exist with the HF procedure between different patients, the
impact on the global circulation is small compared to those of pulmonary power losses and
ventricular power. In addition, the application of a multi-scale model was shown to
accurately capture single ventricle patient physiology, incorporating clinical data for
customized virtual planning and prediction of the stage 2 procedure, as well as utility in
modeling systemic behaviors under different physiological states. Results show that
differences in hemodynamic factors in different patient geometries can be accentuated by
higher stress physiologic conditions, such as increased activity. The unique contributions of
this study include the examination of different physiological conditions using a closed-loop
multi-scale model, and the examination of parameters relevant to both thrombotic risk and
energy loss. The results of this study provide an evaluation on the relative importance of
various considerations for the clinical procedure design for the stage 2 surgery.
Thorough analyses on a sufficient population size are required in order to warrant
changes in clinical procedures based on virtual simulation results. Future studies will apply
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these simulation methods to a larger number of patients, and examine additional parameters
such as ventricular function, and compare different surgical options for the Stage 2 surgery.
Limitations of this study include the need for further validation against both clinical and in vitro
data, use of rigid walls, and a lack of clinical data to precisely model changes in PVR and
other parameters from the pre- to post-operative state.
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TABLE AND FIGURE CAPTIONS
Table 1. Mean Values of Simulated Results.

Pressures and flows are as labeled in figure 3.

Figure 1. Single Ventricle Palliation Surgical Procedures: a) Stage 1, b) Stage 2 HemiFontan. (Figure 1a republished with kind permission from Springer Science and Business
Media, originally published in Pediatric Radiology 2010;40, Cardiovascular magnetic
resonance imaging of hypoplastic left heart syndrome in children, Dillman JR et al, p264,
figure 4, illustration by Anne Phillips, University of Michigan Health System, Department of
Radiology Media Services. Figure 1b produced by Carolyn Nowak, University of Michigan
Health System, Department of Radiology Media Services.)
Figure 2. a) Work Flow of Model Construction From Imaging Data, and Virtual HemiFontan Surgery.
b) Pre-operative 3D Anatomical Models of Patients A & B
Figure 3. The 0D Lumped-parameter Network Model Coupled to the 3D Anatomical Model.
Figure 4. Time-averaged 3D Domain Simulation Results for Patient A. a) Volume-rendered
velocity magnitude (color map) and directions (arrows), b) Wall shear stress distribution.
Figure 5. Time-averaged 3D Domain Simulation Results for Patient B. a) Volume-rendered
velocity magnitude (color map) and directions (arrows), b) Wall shear stress distribution.
Figure 6. Simulated Results of Ventricular Pressure-Volume Loop and SVC Pressure for a)
Patient A, and b) Patient B.
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Table 1.

Patient A
Resting
Active

Patient B
Resting
Active

QAO (mL/s)

16.8

21.0

19.2

24.6

QPV (mL/s)

8.2

12.7

11.3

16.4

QRPV / QPV

0.54

0.53

0.63

0.62

QPV / QAO

0.49

0.60

0.59

0.67

PSA (mmHg)

4.6

4.8

2.4

3.0

PSVC (mmHg)

10.0

11.7

15.4

18.8

PAO (mmHg)

74.9

62.0

53.1

46.3

Wall Shear Stress
(dynes/cm2)

10.62

19.34

20.64

36.05

Particle Residence
Time (s)

0.27

0.18

0.31

0.22

Junction Power
Loss (mW)

0.33

1.01

1.26

3.79

Pulmonary Power
Loss (mW)

5.6

10.7

18.2

30.7

Ventricular Power
(mW)

193

209

168

193
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Figure 1.
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Figure 3.
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Figure 4.

Figure 5.
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Figure 6.
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